Aminoglycoside 6'-N-acetyltransferase variants of the Ib type with altered substrate profile in clinical isolates of Enterobacter cloacae and Citrobacter freundii.

Antimicrobial Agents and Chemotherapy
I CasinE Collatz

Abstract

Three clinical isolates, Enterobacter cloacae EC1562 and EC1563 and Citrobacter freundii CFr564, displayed an aminoglycoside resistance profile evocative of low-level 6'-N acetyltransferase type II [AAC(6')-II] production, which conferred reduced susceptibility to gentamicin but not to amikacin or isepamicin. Aminoglycoside acetyltransferase assays suggested the synthesis in the three strains of an AAC(6') which acetylated amikacin practically as well as it acetylated gentamicin in vitro. Both compounds, however, as well as isepamicin, retained good bactericidal activity against the three strains. The aac genes were borne by conjugative plasmids (pLMM562 and pLMM564 of ca. 100 kb and pLMM563 of ca. 20 kb). By PCR mapping and nucleotide sequence analysis, an aac(6')-Ib gene was found in each strain upstream of an ant(3")-I gene in a sulI-type integron. The size of the AAC(6')-Ib variant encoded by pLMM562 and pLMM564, AAC(6')-Ib7, was deduced to be 184 (or 177) amino acids long, whereas in pLMM563 a 21-bp duplication allowing the recruitment of a start codon resulted in the translation of a variant, AAC(6')-Ib8, of 196 amino acids, in agreement with size estimates obtained by Western blot analysis. Both variants had at position ...Continue Reading

References

Jan 1, 1975·Methods in Enzymology·M J Haas, J E Dowding
Jan 1, 1978·Annual Review of Microbiology·J Davies, D I Smith
Jul 1, 1992·Antimicrobial Agents and Chemotherapy·K J ShawP Downey
Nov 1, 1991·Antimicrobial Agents and Chemotherapy·K J ShawG H Miller
Nov 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M OuelletteP H Roy
Feb 1, 1988·Molecular & General Genetics : MGG·E Martinez, F de la Cruz
Jun 1, 1972·Genetical Research·J M Pemberton, B W Holloway
Aug 1, 1983·Antimicrobial Agents and Chemotherapy·G A JacobyP Mammen
Mar 1, 1981·Journal of Bacteriology·C I Kado, S T Liu
Feb 1, 1994·Protein Engineering·C Geourjon, G Deléage
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·Y CostaP Courvalin
Jul 1, 1993·Molecular Microbiology·C M CollisR M Hall

❮ Previous
Next ❯

Citations

Nov 16, 2001·Antimicrobial Agents and Chemotherapy·A ShmaraM E Tolmasky
Mar 6, 1999·Current Opinion in Microbiology·K Bush, G H Miller
Dec 3, 1998·Antimicrobial Agents and Chemotherapy·P MugnierE Collatz
Oct 18, 2002·Antimicrobial Agents and Chemotherapy·Renee SarnoMarcelo E Tolmasky
Aug 26, 2003·Antimicrobial Agents and Chemotherapy·Ken J DeryMarcelo E Tolmasky
Sep 12, 2007·Antimicrobial Agents and Chemotherapy·Sung-Pin TsengLee-Jene Teng
Feb 23, 2008·EMBO Reports·Frédérique MauriceFrédéric Dardel
Apr 23, 2002·Molecular Microbiology·Béatrice Hanau-BerçotEkkehard Collatz
Oct 22, 2011·The Korean journal of laboratory medicine·Soo-Young KimYeong Sic Kim
Feb 23, 2017·Antimicrobial Agents and Chemotherapy·Sophie RaherisonMarie-Cécile Ploy
Jan 31, 2013·The Journal of Antimicrobial Chemotherapy·María de ToroYolanda Sáenz
May 7, 2009·FEMS Microbiology Reviews·Sally R PartridgeJonathan R Iredell
Jan 11, 2018·Nature Communications·Andrew C PawlowskiGerard D Wright
Apr 28, 2006·Antimicrobial Agents and Chemotherapy·Alfonso J C Soler BistuéAngeles Zorreguieta
Sep 7, 2006·Antimicrobial Agents and Chemotherapy·Chi Hye ParkDavid C Hooper
Apr 4, 2003·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Xiang-Hua YinTeruhiko Tamaya
Sep 14, 2010·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Maria S Ramirez, Marcelo E Tolmasky

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.